Search results for "Antigen"

showing 10 items of 3420 documents

Synthesis and Biological Evaluation of a Multiantigenic Tn/TF-Containing Glycopeptide Mimic of the Tumor-Related MUC1 Glycoprotein

2006

solid-phase synthesisMolecular Sequence DataBreast Neoplasms010402 general chemistrymedicine.disease_cause01 natural sciencesBiochemistryantitumor agentsSolid-phase synthesisAntigenAntigens NeoplasmantigensCell Line TumorDrug DiscoverymedicineHumansAmino Acid SequenceGeneral Pharmacology Toxicology and PharmaceuticsPeptide sequenceMUC1Pharmacologychemistry.chemical_classification010405 organic chemistryMolecular MimicryMucin-1Organic ChemistryTransferringlycopeptidesoxime chemical ligationGlycopeptide0104 chemical sciencesMolecular mimicrychemistryBiochemistryTransferrinMolecular MedicineFemaleGlycoproteinChemMedChem
researchProduct

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer

2022

Simple Summary Non-small cell lung cancer (NSCLC) is the second most commonly diagnosed cancer and the leading cause of cancer-related death worldwide. Clinical decision-making depends on the histological classification; however, tissue biopsy is frequently not technically feasible due to tumor location or limited tissue samples. Therefore, we propose to find clinical, molecular and histological biomarkers using a minimally invasive approach based on the analysis of the cargo of the blood extracellular vesicles. Exosomes are membranous vesicles present in several biological fluids, which carry biological information to distant tissues, regulating several tumor processes. This study aims to …

squamous cell carcinomaCancer ResearchtumorspheresMICRORNASBIOMARKERSCANCER/TESTIS ANTIGENexosomesNSCLCnon-small cell lung cancer; liquid biopsy; exosomes; extracellular vesicles; cell cultures; adenocarcinoma; squamous cell carcinoma; biomarker; tumorspheresMECHANISMSRNASMICROARRAYIMMUNOTHERAPYCàncernon-small cell lung cancerScience & Technologyadenocarcinomaliquid biopsycell culturesSTATISTICSOncologyPulmonsbiomarkerextracellular vesiclesLife Sciences & Biomedicine
researchProduct

The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of m…

1998

SUMMARY In a previous study it was shown that La/SSB contains four linear epitopes, p147–154, p291–302, p301–318 and p349–364. The aim of the present study was to investigate the value of the synthetic epitope analogues of the La/SSB autoantigen for the detection of antibodies to La/SSB, in comparison with recombinant La and fragments of this protein. A total of 122 sera with anti-La/SSB activity, from patients with primary Sjögren's syndrome (pSS) or systemic lupus erythematosus (SLE), were tested in various peptide-based assays. In addition, 62 sera from pSS or SLE patients with other autoantibody specificities and 95 sera from healthy individuals were used as controls. The autoantibody s…

systemic lupusantigenic peptidesMolecular Sequence DataImmunologyDot blotPeptideprimary sjogrens-syndromeBiologyAutoantigensSensitivity and SpecificityEpitopelaw.inventionsjogren's syndromeEpitopesAntigenlawmedicineantibodiesHumansImmunology and AllergyAmino Acid SequenceAutoantibodiesImmunoassaychemistry.chemical_classificationla/ssbcriteriaLinear epitopemedicine.diagnostic_testla ss-bAutoantibodyOriginal Articlessystemic lupus-erythematosusautoantigenRecombinant ProteinsSjogren's SyndromeclassificationRibonucleoproteinschemistryImmunoassayImmunologyRecombinant DNAdiagnostic valueb cell epitopesClinical and Experimental Immunology
researchProduct

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

2020

ABSTRACT Glucocorticosteroids (GCS) have an established role in oncology and are administered to cancer patients in routine clinical care and in drug development trials as co-medication. Given their strong immune-suppressive activity, GCS may interfere with immune-oncology drugs. We are developing a therapeutic cancer vaccine, which is based on a liposomal formulation of tumor-antigen encoding RNA (RNA-LPX) and induces a strong T-cell response both in mice as well as in humans. In this study, we investigated in vivo in mice and in human PBMCs the effect of the commonly used long-acting GCS Dexamethasone (Dexa) on the efficacy of this vaccine format, with a particular focus on antigen-specif…

t-cell primingPremedicationmedicine.medical_treatmentImmunologyPriming (immunology)dexamethasoneglucocorticosteroidsProinflammatory cytokineMice03 medical and health sciences0302 clinical medicineImmune systemAntigenCancer immunotherapyNeoplasmsAnimalsHumansImmunology and AllergyMedicineRC254-282Original ResearchMice Inbred BALB Ccancer immunotherapybusiness.industryrna vaccineImmunityNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC581-607Mice Inbred C57BLCytokineOncology030220 oncology & carcinogenesisImmunologyt-cell vaccineFemaleCancer vaccineImmunologic diseases. AllergybusinessT-cell vaccineResearch Article030215 immunologyOncoImmunology
researchProduct

Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?

2021

The metabolic changes that occur in tumor microenvironment (TME) can influence not only the biological activity of tumor cells, which become more aggressive and auto sustained, but also the immune response against tumor cells, either producing ineffective responses or polarizing the response toward protumor activity. γδ T cells are a subset of T cells characterized by a plasticity that confers them the ability to differentiate towards different cell subsets according to the microenvironment conditions. On this basis, we here review the more recent studies focused on altered tumor metabolism and γδ T cells, considering their already known antitumor role and the possibility of manipulating th…

tumoral metabolismQH301-705.5T-LymphocytesPopulationReviewMajor histocompatibility complexγδ T cellsImmune systemAntigens NeoplasmIn vivomedicineAnimalsHumanstumor microenvironmentBiology (General)educationtumoral metabolism; ?? T cells; tumor microenvironmentClinical Trials as Topiceducation.field_of_studyTumor microenvironmentbiologyReceptors Antigen T-Cell gamma-deltaBiological activityGeneral MedicineHypoxia (medical)Lipid MetabolismIn vitroCell biologybiology.proteinmedicine.symptom
researchProduct

Could PD-1/PDL1 immune checkpoints be linked to HLA signature?

2019

The outstanding clinical expansion of monoclonal antibodies (mAbs) to programmed cell death receptor-1 (PD-1) (nivolumab and pembrolizumab) and PD-1 ligand-1 (PDL-1) (atezolizumab, avelumab and durvalumab) has received an increasing level of interest regarding immunotherapy and multidrug combinations, for the treatment of a number of common human malignancies. Some patients treated with these agents receive remarkable benefits in term of quality of life, progression-free (PFS) and overall survival (OS). However, a significant percentage of these patients experience immune-related adverse events (irAEs), while others present with an ultra-rapid disease progression, defined as hyperprogressio…

vDrug-Related Side Effects and Adverse ReactionsProgrammed Cell Death 1 ReceptorImmunologyAntibodies Monoclon alHuman leukocyte antigenB7-H1 AntigenImmune systemHLA AntigensirAENeoplasmsHumansImmunology and AllergyMedicinePD-1/PDL-1-blockadebusiness.industryAntibodies MonoclonalBiomarkerProgrammed Cell Death 1 ReceptorSignature (logic)HaplotypesOncologyImmunologyoutcomeImmunotherapyHLA alleleDrug-Related Side Effects and Adverse ReactionbusinessBiomarkersB7-H1 AntigenImmunotherapy
researchProduct

Vacunas y evolución: ¿Por qué es importante entender la diversidad genética de los patógenos?

2013

Desde el punto de vista de las intervenciones en salud pública no hay mejor arma que aquella que permite prevenir la transmisión o aparición de la enfermedad. Dentro del campo de las enfermedades infecciosas las vacunas se han convertido en esa arma y han permitido controlar muchas de ellas. Hoy en día hay un gran número de enfermedades infecciosas emergentes para las que no existen vacunas o enfermedades olvidadas que están reemergiendo. Nuevas vacunas se están desarrollando para atacar a los patógenos que están relacionados con ellas. Sin embargo, y a pesar de la importancia del diseño de una buena vacuna, la diversidad genética de los patógenos no se ha tenido siempre en cuenta. El estud…

variación antigénicabiología; evoluciónvariació antigènica; tuberculosi; grip; sistema immune; malalties infecciosesevoluciónantigenic variationinfectious diseasesvariación antigénica; tuberculosis; gripe; sistema inmune; enfermedades infecciosassistema inmunebiologia; evolucióevolutionvariació antigènicagriptuberculosiantigenic variation; tuberculosis; flu; immune system; infectious diseasesbiology; evolutionflubiologygripemalalties infecciosesimmune systemtuberculosisevolucióenfermedades infecciosasbiologíasistema immunebiologia
researchProduct

Pathogenic mechanisms of how human parvovirus breaks self-tolerance

2017

It is known that viral infections can cause acute, chronic, and autoimmune diseases (ADs). However, the mechanism of how a persistent viral infection contributes to ADs remains still unclear. In this thesis, pathological and immunological aspects of how common viruses can initiate autoimmunity were investigated, and human parvovirus B19 (B19V) was employed as a model virus. B19V non-structural protein 1 (NS1), a superfamily 3 (SF3) helicase, initiated DNA damage resulting in cellular apoptosis. The apoptotic bodies (ApoBods) induced by B19V NS1 were purified and characterized. These ApoBods contained viral NS1 proteins with modified autoimmune-associated self-antigens, e.g. DNA, Smith, Apol…

viruksetautoantibodiespatogeneesivirusesautoimmunityapoptosisvasta-aineetinfektiotautoimmuniteettiohjelmoitunut solukuolemaantigeenitimmunologianon-structural protein 1autovasta-aineethuman parvovirus B19apoptotic bodiesself-antigensparvovirukset
researchProduct

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection

2021

The renal involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported. The etiology of kidney injury appears to be tubular, mainly due to the expression of angiotensin-converting enzyme 2, the key joint receptor for SARS-CoV-2; however, cases with glomerular implication have also been documented. The multifactorial origin of this renal involvement could include virus-mediated injury, cytokine storm, angiotensin II pathway activation, complement dysregulation, hyper-coagulation, and microangiopathy. We present the renal histological findings from a patient who developed acute kidney injury and de novo nephrotic syndrome, highly suggestive of acute IgA-domina…

viruses030232 urology & nephrologylcsh:QR1-502Case Report030204 cardiovascular system & hematologylcsh:Microbiology03 medical and health sciences0302 clinical medicineVirologySuperantigenmedicinebusiness.industrySARS-CoV-2MicroangiopathyAcute kidney injuryCOVID-19Glomerulonephritismedicine.diseaseAngiotensin IIVirusCytokine release syndromeInfectious Diseasesacute kidney injuryImmunologybusinessCytokine stormNephrotic syndromeglomerulonephritis
researchProduct

Rab33B and its autophagic Atg5/12/16L1 effector assist in hepatitis B virus naked capsid formation and release

2015

Hepatitis B virus morphogenesis is accompanied by the production and release of non-enveloped capsids/nucleocapsids. Capsid particles are formed inside the cell cytosol by multimerization of core protein subunits and ultimately exported in an uncommon coatless state. Here, we investigated potential roles of Rab GTPases in capsid formation and trafficking by using RNA interference and overexpression studies. Naked capsid release does not require functions of the endosome-associated Rab5, Rab7 and Rab27 proteins, but depends on functional Rab33B, a GTPase participating in autophagosome formation via interaction with the Atg5-Atg12/Atg16L1 complex. During capsid formation, Rab33B acts in conju…

virusesATG8ImmunologyATG5Autophagybiochemical phenomena metabolism and nutritionBiologyGroup-specific antigenMicrobiologyVirus ReleaseCell biologyATG12CapsidVirologyRabCellular Microbiology
researchProduct